Frequency Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Korro Bio

10/08/2022 13:30

* Frequency Therapeutics Inc  FREQ.OQ  reported a quarterly
adjusted loss of 61 cents​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 67 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Frequency Therapeutics Inc's reported EPS for the quarter
was a
loss of 61 cents​.
    * The mean earnings estimate of analysts had risen by
about 2.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Frequency Therapeutics Inc shares had risen by 33.3% this
quarter and lost 61.0% so far this year.
    * The company reported a quarterly loss of $21.29 million.
    * Wall Street's median 12-month price target for Frequency
Therapeutics Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 10
at 12:30 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.67          -0.61          Beat
 Mar. 31 2022      -0.63          -0.67          Missed
 Dec. 31 2021      0.15           -0.62          Missed
 Sep. 30 2021      -0.57          -0.73          Missed